Reuters logo
BRIEF-FDA grants orphan drug designation to CSRA's Dynport Vaccine Company for plague vaccine
March 8, 2017 / 3:45 PM / 9 months ago

BRIEF-FDA grants orphan drug designation to CSRA's Dynport Vaccine Company for plague vaccine

March 8 (Reuters) - CSRA Inc :

* FDA grants orphan drug designation to CSRA’s Dynport Vaccine Company for plague vaccine

* CSRA Inc- Plague vaccine being developed by its subsidiary, Dynport Vaccine Company LLC was granted orphan drug designation from FDA Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below